ArticleOncoimmunology2022

Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer.

Xiaohuan Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.